Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Surgical & Medical Instruments & Apparatus

Shockwave Medical, Inc. to acquire Neovasc Inc

Announced Jan 17, 2023 · Closed Apr 11, 2023

Deal value$100MEV $100M
Premium—To unaffected price
EV / Adj. EBITDA—39.3x EV / Revenue
ConsiderationAll cash$27.25 per share

Transaction

Acquirer
Shockwave Medical, Inc. (SWAV)
Target
Neovasc Inc
Buyer type
Strategic
Offer price per share
$27.25
Enterprise value
$100M
Status
Closed Apr 11, 2023

Deal protections

Not yet read from the merger agreement.

Advisors

To the acquirer
Not disclosed
To the target
Not disclosed

Sector context · Healthcare

Comparable deals
73 in the prior 24 months
Premium
Sector median 50.0%
EV / Adj. EBITDA
Sector median 20.4x
Break fee
Sector median 3.4%

Timeline

  1. AnnouncedJan 17, 2023
  2. ClosedApr 11, 2023
Sources
  • 8-K (EX-99.1) · Jan 17, 2023

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.